Skip to main content

Ongoing FDAEvent 99349 (2 months ago)

Beckman Coulter MicroScan LabPro Panel Update Software

MicroScan LabPro V5.03 Panel Update 11 has incorrect algorithms that may affect antimicrobial susceptibility test results.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

Beckman Coulter Inc., of Brea, California, recalled MicroScan LabPro V5.03 Panel Update 11 DVD Kit and MicroScan LabPro V5.03 Panel Update 11 (US) because analyzers contain incorrect algorithms that may affect antimicrobial susceptibility test results, leading to false susceptibility classifications. The recall began June 26, 2026, and was added to the FDA's Enforcement Report on August 5, 2026.

The products were distributed nationwide in the United States, including in states such as Alaska, California, Florida, and Texas.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is your kit affected?

2 products

Affected if its UDI-DI is listed.

  1. REF # D23354, MicroScan LabPro V5.03 Panel Update 11 DVD Kit (US) on

    UDI-DI
    • 15099590799250
  2. REF # D23352, MicroScan LabPro V5.03 Panel Update 11 (US), Electronic installed on

    UDI-DI
    • 15099590799243

Details

Company began the recall
Event ID
99349
Recall numbers
Z-2888-2026 to Z-2889-2026
Company
Beckman Coulter Inc.Brea, California
Recall type
Voluntary: Firm initiated
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

All recalls from Beckman Coulter Inc.

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration